Table 2.

Treatment‐emergent, all‐causality adverse events in ≥3 patients

N = 13	Treatment‐emergent, all‐causality adverse events
	All grades n (%)	≥Grade 3 n (%)
Any adverse event	13 (100.0)	7 (53.8)
Dysgeusia	9 (69.2)	0
Constipation	6 (46.2)	0
Decreased appetite	6 (46.2)	0
Muscle spasms	6 (46.2)	0
Pyrexia	6 (46.2)	1 (7.7)
Alopecia	4 (30.8)	0
Blood creatinine phosphokinase increased	3 (23.1)	0
Diarrhea	3 (23.1)	0
Fatigue	3 (23.1)	0
Hypokalemia	3 (23.1)	2 (15.4)
Thrombocytopenia	3 (23.1)	3 (23.1)
Weight decreased	3 (23.1)	0